Rieger syndrome is most often associated with mutations in the PITX2 gene on chromosome 4p25. The PITX2 protein is a transcription factor containing a bicoid-type homeodomain. Homeodomains are highly conserved regions within multigene families that are usually required to bind to a specific DNA sequence of selected target genes. Homeodomain-containing transcription factors are often involved in early development. Mutations in the PITX2 gene, which range from single basepair substitutions to null deletions, can result in highly variable phenotypes even within the same family. In addition to Rieger syndrome, mutations in the PITX2 gene have been associated with iridogoniodysgenesis, iris hypoplasia, and Peter's anomaly. The phenotypic variation within Rieger syndrome has been attributed to haploinsufficiency. Recently, a dominant negative homeodomain missense mutation in the PITX2 gene was identified and a model proposed that might partially explain the variable phenotype [3] .
In addition to the PITX2 gene (4p25), Rieger syndrome also has been associated with chromosomal 13q14 and 6p25. Recently, a case of Rieger syndrome associated with a deletion in the PAX6 gene on chromosome 11p13 was reported [4] .
Axenfeld-Rieger anomaly
Axenfeld-Rieger anomaly encompasses the same ocular malformations as Rieger syndrome but does not have the associated systemic anomalies. Genetic linkage analyses have associated Axenfeld-Rieger anomaly with chromosome 6p25. Most cases of Axenfeld-Rieger anomaly linked to 6p25 have mutations in FOXC1 (formerly FKHL7), a member of the forkhead/winged-helix transcription factor family. Mutations ranging from single missense mutations to null defects have been identified in affected cases, suggesting that haploinsufficiency accounts for the phenotype. Mutational screening and genetic-linkage analyses excluded FOXC1 from underlying the anterior-segment disorders in two families with linkage to 6p25 [5] . This suggested the existence of a second gene responsible for Axenfeld-Rieger anomaly that maps to 6p25. However, two recent studies identified several affected families with a chromosomal duplication of the 6p25 region [6••,7••] . Although these findings do not rule out the existence of a second gene at 6p25, they may account for the lack of FOXC1 mutations found in some affected families, without the need for a second gene. The extra allele in these affected families suggests that alterations (up or down) in gene dosage of FOXC1 cause the ocular abnormalities. Eye disorders associated with FOXC1 defects may be a rare documented example of a clinical phenotype resulting from both the deletion and duplication of a single gene [8] .
The FOXC1 gene may also function in the adult eye. Expression of the FOXC1 gene was recently found, in decreasing amounts, in the trabecular meshwork, optic nerve head, RPE/choroid, ciliary body, cornea and iris [9] . Much lower levels were found in nonocular tissues such as liver, muscle, lung, heart, and kidney.
Congenital glaucoma
Although most cases of primary congenital glaucoma are sporadic in occurrence, analysis of affected families support an autosomal recessive inheritance pattern. The disorder has been linked genetically to at least two chromosomal loci and for one locus, the responsible gene was identified as CYP1B1. CYP1B1 is a form of cytochrome P450, however its role in the developing eye is not un- 
Primary open-angle glaucoma
Autosomal dominant primary open-angle glaucoma (GLC1C)
Although large families with multiple members affected by primary open-angle glaucoma (POAG) are rare, such pedigrees are extremely useful for localizing the disorder to a specific chromosomal location. The process of genetic linkage analysis has enable researchers to identify the location of least six different genes for POAG (GLC1A-GLC1F). Most loci have been reported only in a single large pedigree. However, a recent report described the second pedigree linked to the GLC1C locus on chromosome 3q, and haplotype analysis in the two families suggested an independent origin of the genetic defect [12, 13] . A potential candidate gene at this chromosomal region has been described [14] . The PCOLCE2 gene is expressed in the trabecular meshwork, has homology with collagen-binding proteins, and localizes to GLC1C locus (3q21-24). However, no coding sequence mutations were detected in PCOLCE2 in a POAG patient from a GLC1C family.
Inheritance patterns in the Barbados Family Study
The 
Specific genes and primary open-angle glaucoma
Because of the potential role of oxidative damage in the development of glaucoma, a recent study examined the association between the presence of glaucoma in Estonians and different variants of glutathione S-transferase (GST), a family of detoxification enzymes that catalyze conjugation of foreign and endogenous substances with glutathione [18] . The frequency of the GSTM1 positive individuals among the 250 glaucoma patients was significantly higher than in the group of 202 controls (60% vs 45%; odds ratio 1.83; P = 0.002). The risk was even higher among the smokers with glaucoma (63% vs 33%; odds ratio 3.36; P = 0.012).
Another gene that may play a role in glaucoma was examined recently for mutations in Chinese POAG subjects. Trabecular meshwork-inducible stretch response (TISR)/oculomedin gene was initially identified in human trabecular meshwork cell culture that were subjected to mechanical stretch [19] . It has homology with neurokinins, which may modulate contractility of the trabecular meshwork [20] . The DNA sequence of the promoter and coding region was determined for 110 POAG patients and 108 controls, but no common TISR/oculomedin coding or promoter mutation that causes POAG was found [21] .
Molecular genetic techniques have been used recently to identify altered gene expression in lymphocytes of persons with vasospastic normal tension glaucoma [22] . Using subtraction hybridization to compare mRNA from 6 normal tension glaucoma patients with mRNA from 6 controls, the researchers found that genes encoding for p53-protein, a neural thread protein, and 20 S proteasome subunit XAPC7 were overexpressed, whereas those encoding for XPGC, survivin protein, and a ABC transport protein were underexpressed. Although it is unclear how these genes relate to normal tension glaucoma, they do have important functions in other diseases. For example, p53-protein acts as a tumor suppressor and a pro-apoptotic factor, whereas survivin is an apoptosis inhibitor and is overexpressed in many human cancers.
Exfoliation (pseudoexfoliation) syndrome
Exfoliation syndrome occurs primarily in the elderly and is characterized by the accumulation of abnormal fibrillar extracellular material in the anterior segment as well as other ocular and nonocular structures [23] . It is highly associated with glaucoma and is the most common identifiable cause of open-angle glaucoma. It is particularly common in Scandinavian countries where it accounts for most cases of glaucoma [24] .
Few descriptions exist of the familial occurrence of exfoliation syndrome. Because of the advanced age at which exfoliation syndrome is diagnosed, relatives of affected individuals may be either deceased or too young to be affected. Recently however, six Icelandic families affected by exfoliation syndrome have been described [25] . In all six cases where determination was possible, transmission to the second generation was through an affected mother. A similar, maternal transmission pattern has been reported earlier, suggesting that exfoliation syndrome is transmitted by mitochondrial inheritance, X-linked inheritance, or autosomal inheritance with genetic imprinting [26] . Further studies are needed to determine the genetic inheritance of exfoliation syndrome.
Pigment dispersion syndrome
Pigment dispersion syndrome is a common disorder that may progress to pigmentary glaucoma. Up to half of persons with pigment dispersion syndrome will develop sustained elevation of IOP [27] . Major risk factors for the development of pigment dispersion syndrome include male gender, young age (20-45 years), myopia, and white race [28] .
Pigment dispersion syndrome and pigmentary glaucoma seem to be transmitted in an autosomal dominant inheritance pattern [29, 30] . Several families with pigment dispersion syndrome have been genetically linked to chromosome 7q36 or 18q [30, 31] . Recently, six more families with autosomal dominant pigment dispersion syndrome have been described [32] .
Although white race is a risk factor for pigment dispersion syndrome, this disorder does occur infrequently in other races. One study queried 10 black persons with pigment dispersion syndrome about their racial heritage. All ten subjects reported some degree of white heritage whereas less than half of 101 black controls without pigment dispersion syndrome reported any white heritage (P = 0.001) [33] . This finding suggests that white heritage may be important for the transference of genes responsible for this disorder in blacks and for its severity in affected individuals.
Intraocular pressure and genetics
The Melbourne Visual Impairment Project, a population-based study of the prevalence of and risk factors for age-related eye diseases, studied the distribution and associations of demographic, familial, medical, and ocular factors with intraocular pressure (IOP) among 4576 residents of Victoria, Australia [34] . In those with untreated glaucoma, family history of glaucoma and country of birth were significantly associated with IOP in multivariate models whereas in those without glaucoma, other factors seem to play a greater role. The association between family history of glaucoma and IOP confirms findings of other population-based studies [35, 36] . The Melbourne Project, however, differed from the other studies in its stratification based on glaucoma status. In persons without glaucoma, family history of glaucoma was not statistically associated with IOP.
Stress response and glaucoma
A recent study identified endothelial leukocyte adhesion molecule-1 (ELAM-1) as a disease marker for glaucomatous trabecular meshwork [37••] . Reasoning that glaucoma results from chronic injury due to cellular stress, the researchers screened several cell-adhesion molecules that are upregulated in vascular endothelium in response to cellular stress. ELAM-1 was consistently present on trabecular meshwork cells of eyes with glaucomas of different types but absent from non-glaucomatous eyes. The researchers also determined that ELAM-1 expression is controlled by activation of an interleukin-1 autocrine feedback loop through transcription factor NF-B. This NF-B-mediated stress response appears to protect trabecular meshwork cells from oxidative stress. These findings provide new insights into the pathogenesis of glaucoma and open up new areas for investigation.
Myocilin
Since its role in autosomal dominant juvenile onset POAG was identified, the MYOC gene has been the most extensively studied gene relating to glaucoma. During the past few years, much has been learned about the expression of this gene but still much is unknown about the function of its protein, myocilin [38] .
MYOC expression in the trabecular meshwork
Myocilin protein was originally identified in cultured trabecular meshwork cells exposed to glucocorticoids [39] . Because mutations in the MYOC gene were initially associated with high-tension juvenile glaucoma [40] , much research has concentrated on the biology of myocilin in the trabecular meshwork. Recent work has focused on localization of myocilin to specific intracellular and extracellular compartments in the presence or absence of glucocorticoid stimulation. Using immunohistochemistry techniques, several groups have localized myocilin protein to mitochondria, discrete perinuclear deposits and cytoplasmic filaments of TM cells; the cell surface associated with the extracellular matrix; elastic-like fibers in trabecular beams; and extracellular matrices in the juxtacanalicular region [41,42•] . Under electron microscopy, myocilin immunostaining was detected in the extracellular matrix in association with the long-spacing collagen, fine granular materials and possibly microfibrils [43] . With double immunohistochemistry, MYOC/TIGR was colocalized with type VI collagen in the trabecular meshwork. No notable differences were detected in staining among several different types of glaucoma, or between eyes with and those without a mutation in the MYOC gene [43] .
Secreted myocilin protein has been detected in medium of cultured trabecular meshwork cells exposed to glucocorticoid [42•,44] . Indeed, relatively abundant amounts of myocilin protein are found in human aqueous humor, most likely as a complex rather than a monomer [45] [46] [47] [48] . Interestingly, truncated forms of myocilin were not detectable in the aqueous humor from patients with the Gln368STOP mutation [47•]. These results suggest that secretory myocilin may affect outflow resistance, perhaps based on solubility characteristics of normal and mutant protein [49] . In perfusion organ culture, eyes receiving an anterior segment exchange with recombinant myocilin protein had increased intraocular pressure and increased outflow resistance compared with eyes receiving an exchange with control proteins [50•].
MYOC expression in the optic nerve head
MYOC gene expression and myocilin protein have been identified in multiple ocular tissues. Early work had identified myocilin in the trabecular meshwork, ciliary body, and retina [51] [52] [53] . Several groups have used in situ hybridization to identify MYOC mRNA in the optic nerve head [54•,55] . Transcripts have been found in the retrolaminar pial septa that divide the nerve fiber bundles, the perivascular connective tissue surrounding the central retinal vessels, and the dura mater, arachnoid, and pia mater of the meningeal sheath surrounding the optic nerve [54•]. Moreover, MYOC mRNA transcripts were detected in cultured human lamina cribosa cells and optic nerve head astrocytes [55] .
Myocilin protein has been localized by immunohistochemistry to the axons of the ganglion cells, prelaminar, laminar, and poslaminar optic nerve; optic nerve astrocytes; and postlaminar pial septa [55, 56] . Cultured human lamina cribosa cells and astrocytes express both intracellular and extracellular forms of myocilin [55] . In porcine optic nerve astrocytes, myocilin was localized in the nucleus, centrosome, glial filament, mitochondria, some parts of cell membranes, and at the edge-feet portion of the processes of astrocytes adjacent to the inner limiting membrane and blood vessel wall [57•].
MYOC gene and steroid-response ocular hypertension
Because steroids can dramatically stimulate MYOC gene expression in trabecular meshwork cells, it is reasonable to examine the role of myocilin in steroid-induced elevations in intraocular pressure. In a recent study, 70 individuals with known steroid-induced ocular hypertension along with 114 controls were screened for variations in the coding sequence and promoter of MYOC [58•]. Of only four possible phenotype-altering variations, three were present in steroid responders and one in a control patient, a distribution that was not statistically significant. Moreover, the allele frequency of a closely flanking marker was compared between the steroid responders and the control subjects, and no evidence for linkage disequilibrium was observed. Hence, this study found no statistically significant evidence for a link between MYOC mutations and steroid-induced ocular hypertension. This study, however, does not rule out a potential role of nonmutant myocilin in steroid-induced pressure elevations.
Analysis of myocilin mutants
Several recent reports describe the behavior of myocilin mutants that have a truncated or altered olfactomedin domain [47•,59,60•] . Using adenovirus vectors to introduce a mutant or normal myocilin gene into cultured trabecular meshwork cells, two groups have found that mutated myocilin protein is poorly secreted and actually suppresses normal myocilin secretion. These results suggest that glaucoma due to myocilin mutations may involve intracellular accumulation of misfolded proteins, compromised TM cell function caused by congestion of the TM secretory pathway, or insufficient levels of secreted myocilin.
Myocilin mutations
Several novel mutations in the MYOC gene have been recently reported in Japanese glaucoma patients [61] [62] [63] [64] . The frequency of MYOC mutations in Japanese primary open angle glaucoma (2.9%) seems to be similar to other ethnic groups [61] .
The Glaucoma Inheritance Study in Tasmania identified eight pedigrees with the Gln368STOP, the most common MYOC mutation [65, 66] . Within the eight families, however, only half of the members with POAG or ocular hypertension carried the Gln368STOP mutation and not all of the mutation carriers had evidence of POAG or ocular hypertension. Hence, although myocilin mutations are the most commonly known genetic cause of glaucoma, they only account for a small portion of glaucoma overall.
Conclusions
Much progress has been achieved over the past few years on understanding the genetic basis of glaucoma and glaucoma-related disorders. Although only a small percentage of glaucoma overall has a known genetic basis, as we continue to understand more about the known genes, we undoubtedly will learn more about the mechanisms of other types of glaucoma. Multiple putative genes on chromosomal loci linked to glaucoma have yet to be identified. As more pedigrees are studied and candidate genes analyzed, new glaucoma genes will be identified. In addition, recent developments in microarray technology, sequencing of the human genome, and bioinformatics may enhance our investigations into the genetic basis of glaucoma. ••
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